The effect of 1α(OH)D3 and 1α,25(OH)2D3 on the bone in patients with renal osteodystrophy (Q43433627)

23 November 2017

title

The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A623125

16 July 2022

The effect of 1α(OH)D3 and 1α,25(OH)2D3 on the bone in patients with renal osteodystrophy (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

13 August 2023

author name string

P. Bordier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A623125

16 July 2022

J. Zingraff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A623125

16 July 2022

J. Gueris

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A623125

16 July 2022

P. Jungers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A623125

16 July 2022

P. Marie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A623125

16 July 2022

M. Pechet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A623125

16 July 2022

H. Rasmussen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A623125

16 July 2022

language of work or name

English

0 references

publication date

1 January 1978

1 reference

full work available at URL

23 November 2017

https://api.elsevier.com/content/article/PII:0002934378901845?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

https://api.elsevier.com/content/article/PII:0002934378901845?httpAccept=text/plain

13 August 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

American Journal of Medicine

13 August 2023

published in

1 reference

23 November 2017

volume

64

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

101-107

1 reference

Editorial: Vitamin D, the kidney and calcium homeostasis

23 November 2017

cites work

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation

13 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

13 August 2023

Bone disease in uremia

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

The role of the liver in the metabolism of vitamin D.

13 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite

13 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

Regulation of vitamin D metabolism and function

13 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

Vitamin D metabolism in experimental uraemia: effects on intestinal transport 45 Ca and on formation of 1,25-dihydroxycholecalciferol in rat

13 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats

13 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man.

13 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure

13 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure

13 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy

13 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.

13 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

Skeletal Resistance to Endogenous Parathyroid Hormone in Patients with Early Renal Failure. A Possible Cause for Secondary Hyperparathyroidism

13 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3

13 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

1-alphahydroxycholecalciferol in chronic renal failure. Studies of the effect or oral doses

13 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

HEPARIN ENHANCEMENT OF FACTORS STIMULATING BONE RESORPTION IN TISSUE CULTURE

13 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

13 August 2023

HEPARIN OSTEOPOROSIS

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90184-5

13 August 2023

Identifiers

1 reference

23 November 2017

1 reference